Element Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Element Solutions Inc

Element Solutions (NYSE: ESI) is set for a proposed acquisition by Solstice Advanced Materials, with consideration of $10.00 in cash plus 0.500 shares of Solstice stock for each Element share. Former Louisiana Attorney General Charles C. Foti Jr. and Kahn Swick & Foti are investigating the proposed sale. The headline is likely more meaningful for ESI’s stock due to takeover terms, but no deal valuation or guidance impact is quantified in the excerpt.

Analysis

This is less a fundamental catalyst than a spread-trading event: the key variable is not the target’s standalone earnings path, but whether the market trusts the acquirer’s stock as stable consideration through closing. That makes SOLS the more important risk asset in the near term; any weakness in its shares mechanically tightens the implied value to ESI holders and can widen the arb spread even if the deal remains intact. If the consideration mix is unchanged, ESI should trade like a discounted claim on the announced package rather than on its operating fundamentals.

The first-order winners are merger-arb capital and any competing buyers that can now signal disciplined, higher-bid optionality. The main loser is SOLS equity if investors conclude it is being used as acquisition currency at a rich multiple or with excessive dilution. Second-order, this kind of deal can compress valuations across adjacent specialty-materials names if the market reads it as evidence that boards are preferring cash-plus-stock exits over standalone compounding.

Time horizon matters: over days, headlines around the investigation are usually noise unless they uncover process flaws or a go-shop breach; over 1-3 months, the trade is driven by spread behavior, financing certainty, and SOLS earnings volatility; over 6-18 months, the question becomes whether the combined company can justify any synergy premium versus the dilution. The contrarian view is that routine legal review rarely kills a signed transaction, so an overreaction in ESI downside may create a cleaner arb entry than a directional short. The thesis is falsified if SOLS stabilizes, the spread converges toward the implied package, or any regulatory/contract disclosure materially raises break risk.

Key Decisions for Investors

• Watch ESI vs. implied package value as a merger-arb pair: go long ESI / short SOLS only if the spread materially widens beyond the cost of carry and break risk; target a low-double-digit annualized return with defined downside if the deal is terminated.
• If already long SOLS, hedge event risk with a partial short against ESI consideration sensitivity; this isolates deal-spread exposure and reduces beta if SOLS sells off on dilution concerns.
• Avoid naked SOLS shorting into the headline unless new disclosures show financing or fiduciary-process issues; the legal review alone is usually insufficient to justify a clean directional short.
• Set a 1-3 month alert for any revised proxy, fairness opinion, or antitrust/financing update; if none appears and the spread tightens, trim rather than chase.
• For more aggressive traders, consider a small ESI call spread financed by SOLS puts only if the arb spread becomes excessively wide; otherwise the asymmetry is weak and the setup is likely not worth forcing.